603658 Autobio Diagnostics
- 47.98
- -1.87-3.75%
Autobio Diagnostics News
Autobio Diagnostics (603658.SH) has repurchased 0.4005% of its shares.
On June 3, Gelon Hui reported that Autobio Diagnostics (603658.SH) has announced that, as of May 31, 2024, the company has accumulated 2,347,970 shares through centralized bidding buy-back, accounting for 0.4005% of the total share capital of the company. The highest transaction price was 59.99 yuan/share, the lowest price was 51.54 yuan/share, and the total amount paid was 129,808,722.60 yuan (excluding transaction fees).
Antu Biotech (603658.SH) plans to pay 1.05 yuan per share in 2023, excluding interest on June 5
Antu Biotech (603658.SH) announced that the company plans to pay a cash dividend of 1.05 yuan per share in 2023,...
Autobio Diagnostics' Unit Gets Nod for Two Products
Chinese medical laboratory technology company Autobio Diagnostics' (SHA:603658) unit, Antu Experimental Instruments (Zhengzhou), received medical device registration certificates from the drug registr
Shareholders in Autobio Diagnostics (SHSE:603658) Are in the Red If They Invested Three Years Ago
Many investors define successful investing as beating the market average over the long term. But the risk of stock picking is that you will likely buy under-performing companies. We regret to report
Antu Biotech (603658.SH): Wholly-owned subsidiary obtains medical device registration certificate
Antu Biotech (603658.SH) announced that Antu Laboratory Instruments (Zhengzhou) Co., Ltd., a wholly-owned subsidiary of the company, recently...
Antu Biotech (603658.SH): 0.3250% of shares have been repurchased cumulatively
Gelonghui, May 6, 丨 Antu Biotech (603658.SH) announced that as of April 30, 2024, the company had repurchased 1,905,370 shares through centralized bidding transactions, accounting for 0.3250% of the company's total share capital. The highest transaction price was 59.99 yuan/share, the lowest price was 51.54 yuan/share, and the total amount paid was 105,168,612.90 yuan (not including transaction fees).
Antu Biotech (603658.SH): Chairman and actual controller Miao Yongjun increased the company's shares by 503.68 million yuan
Gelonghui, April 23 | Antu Biotech (603658.SH) announced that on April 23, 2024, Mr. Miao Yongjun, the chairman and actual controller of the company, increased his holdings of the company's shares by 901,200 shares through centralized bidding transactions, accounting for 0.1537% of the company's total share capital. The total amount of this increase in holdings was 503.68 million yuan.
Earnings Beat: Autobio Diagnostics Co., Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
The first-quarter results for Autobio Diagnostics Co., Ltd. (SHSE:603658) were released last week, making it a good time to revisit its performance. The results were mixed; although revenues of
Autobio Diagnostics' Q1 Profit Jumps 34%
Autobio Diagnostics' (SHA:603658) attributable profit rose 34% year over year to 324.2 million yuan in the first quarter, according to a Friday filing with the Shanghai bourse. Earnings per share at t
Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat
Autobio Diagnostics' (SHA:603658) attributable profit rose 4.3% to 1.22 billion yuan in 2023 from 1.17 billion yuan in 2022, according to a Friday filing with the Shanghai bourse. Earnings per share a
Autobio Diagnostics Co., Ltd.'s (SHSE:603658) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 13% over the past month, it is easy to disregard Autobio Diagnostics (SHSE:603658). But if you pay close attention, you might gather that its strong financials could mean that th
Antu Biotech (603658.SH) has repurchased a total of 1.02% of its shares at a cost of 283 million yuan
Zhitong Finance App News, Antu Biotech (603658.SH) announced that as of April 3, 2024, the two share repurchase plans implemented by the company had repurchased a total of 5.9625 million shares through centralized bidding transactions, accounting for 1.0170% of the company's total share capital. The highest purchase price was RMB 59.99 yuan/share, the lowest price was RMB 42.32 per share, and the total amount paid was RMB 283 million (not including transaction fees).
Antu Biotech (603658.SH): A total of 497,400 shares have been repurchased
Gelonghui, April 1, 丨 Antu Biotech (603658.SH) announced that as of March 29, 2024, the company had repurchased 497,440 shares through centralized bidding transactions, accounting for 0.0848% of the company's total share capital. The highest transaction price was 59.99 yuan/share, the lowest price was 55.80 yuan/share, and the total amount paid was 28,682,040 yuan (excluding transaction fees).
Autobio Diagnostics Secures Registration Certificates for 11 Devices
Autobio Diagnostics (SHA:603658) obtained registration certificates from the food and drug regulator of China's Henan province for 11 medical devices, the company said in its disclosure on the Shangha
Antu Biotech (603658.SH) received 11 medical device registration certificates
Antu Biotech (603658.SH) issued an announcement. The company recently received a total of...
Qiu Dongrong's hidden heavy stock positions released
The fund's annual reports began to be disclosed one after another, and Qiu Dongrong was one of the first “outstanding students” to submit documents. Qiu Dongrong currently manages 5 funds, namely Zhonggeng Value Pilot, Zhonggeng Small Cap Value, Zhonggeng Value Agile, Zhonggeng Value Quality One-Year Holding Period and Zhonggeng Hong Kong Stock Connect Value Closed Operation for 18 months. The total management scale is 23.782 billion yuan. At the end of 2023, Qiu Dongrong's invisible stocks were Antu Biotech, Kanghua Biotech, COSCO Haineng, Bozhong Precision, Zero Sports Auto, Saisheng Pharmaceutical, Huatong Co., Ltd., Eddy Pharmaceuticals, China Overseas Hongyang Group, and Kuaishou-W. It is worth noting that Qiu Dongrong's masterpiece, Zhong Geng Value Leader, was bought in large quantities
These 4 Measures Indicate That Autobio Diagnostics (SHSE:603658) Is Using Debt Reasonably Well
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Gongdong Medical (605369.SH) plans to establish a joint venture with Antu Biotech (603658.SH) to focus on the field of medical polymer consumables
Gongdong Medical (605369.SH) announced that the company plans to invest no more than RMB 60 million and Zhengzhou Antusheng...
Antu Biotech (603658.SH): 70,000 shares have been repurchased
Gelonghui, March 1, 丨 Antu Biotech (603658.SH) announced that as of February 29, 2024, the company had repurchased 70,100 shares through centralized bidding transactions, accounting for 0.0120% of the company's total share capital. The highest transaction price was 59.81 yuan/share, the lowest price was 57.41 yuan/share, and the total amount paid was 4,102,048 yuan (not including transaction fees).
Earnings Not Telling The Story For Autobio Diagnostics Co., Ltd. (SHSE:603658) After Shares Rise 26%
The Autobio Diagnostics Co., Ltd. (SHSE:603658) share price has done very well over the last month, posting an excellent gain of 26%. Unfortunately, the gains of the last month did little to right
Analysis
Price Target
No Data
